Your browser doesn't support javascript.
loading
ERK: A Double-Edged Sword in Cancer. ERK-Dependent Apoptosis as a Potential Therapeutic Strategy for Cancer.
Sugiura, Reiko; Satoh, Ryosuke; Takasaki, Teruaki.
Affiliation
  • Sugiura R; Laboratory of Molecular Pharmacogenomics, Department of Pharmaceutical Sciences, Faculty of Pharmacy, Kindai University, Osaka 577-8502, Japan.
  • Satoh R; Laboratory of Molecular Pharmacogenomics, Department of Pharmaceutical Sciences, Faculty of Pharmacy, Kindai University, Osaka 577-8502, Japan.
  • Takasaki T; Laboratory of Molecular Pharmacogenomics, Department of Pharmaceutical Sciences, Faculty of Pharmacy, Kindai University, Osaka 577-8502, Japan.
Cells ; 10(10)2021 09 22.
Article in En | MEDLINE | ID: mdl-34685488
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Apoptosis / MAP Kinase Signaling System / Protein Kinase Inhibitors / Neoplasms Limits: Humans Language: En Journal: Cells Year: 2021 Document type: Article Affiliation country: Japón Country of publication: Suiza
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Apoptosis / MAP Kinase Signaling System / Protein Kinase Inhibitors / Neoplasms Limits: Humans Language: En Journal: Cells Year: 2021 Document type: Article Affiliation country: Japón Country of publication: Suiza